Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42
Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42
雷蒙德·詹姆斯以跑贏大盤的評級發起對Pacira BioSciences的報道,宣佈目標股價爲42美元
Raymond James analyst Gary Nachman initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Outperform rating and announces Price Target of $42.
雷蒙德·詹姆斯分析師加里·納赫曼以跑贏大盤的評級開始對Pacira BioSciences(納斯達克股票代碼:PCRX)進行報道,並宣佈目標股價爲42美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。